Hospital Medicine

Supportive Care

Questions discussed in this category

Can defibrotide be given safely for VOD in patients with refractory thrombocytopenia to platelet transfusions?

1 Answer available

What is the appropriate management of severe myalgia during atezolizumab infusion?

1 Answer available

What is your institutional approach to a restrictive “neutropenic diet”?

3 Answers available

How do you counsel patients regarding initiation of total parenteral nutrition (TPN) with malignant small bowel obstruction?

1 Answer available

Papers discussed in this category

Journal of hospital medicine, 2018-08-01

Things We Do For No Reason: Neutropenic Diet.

Front Oncol, 2022 Mar 09

Neutropenic Diet Cannot Reduce the Risk of Infection and Mortality in Oncology Patients With Neutropenia.

BMJ Support Palliat Care, 2022 Jul 08

Neutropenic versus regular diet for acute leukaemia induction chemotherapy: randomised controlled trial.

Nutr Cancer, 2019 Oct 12

Lack of Efficacy of the Neutropenic Diet in Decreasing Infections among Cancer Patients: A Systematic Review.

J Clin Oncol, 2021 Dec 20

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update.

J Natl Compr Canc Netw,

Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology.

J Immunother Cancer, 2021 Jun

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events.

Ann Oncol, 2022 Oct 18

Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

Blood, 2016-03-31

Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure.

Bone marrow transplantation, 2016-07

Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation.

Bone marrow transplantation, 2018-02

Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and marrow transplantation.

British journal of haematology, 2020 Mar 04

Modified diagnostic criteria, grading classification and newly elucidated pathophysiology of hepatic SOS/VOD after haematopoietic cell transplantation.

Blood advances, 2022 Jan 11

Defibrotide: real-world management of veno-occlusive disease/sinusoidal obstructive syndrome after stem cell transplant.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2020 Jan-Dec

A Meta-Analysis Evaluating the Incidence of Bleeding Events With Intravenous Defibrotide Treatment Outside the Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome Setting.

Bone marrow transplantation, 2022 Dec 23

Real-world use of defibrotide for veno-occlusive disease/sinusoidal obstruction syndrome: the DEFIFrance Registry Study.

Related Topics in Hospital Medicine